Patients with diabetes mellitus are prone to develop severe hepatitis and liver failure due to hepatitis virus infection

Journal of Clinical and Experimental Hepatology

Volumn 3, Issue 4, 2013, Pages 275-280

  Singh, Kumar K ^a   Panda, Subrat K ^a   Shalimar, ^a   Acharya, Subrat K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acute viral hepatitis; ALF; ALT; AVH; BMI; Diabetes; HAV; HBV; HEV; LFT; NAFLD; Severe hepatitis

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS E; HUMAN; INCIDENCE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; VIRUS HEPATITIS;

EID: 84890873116     PISSN: 09736883     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jceh.2013.11.003     Document Type: Article

References (35)

1. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053.
2. Dixon J.B., Bhathal P.S., O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001, 121:91-100.
3. Matteoni C.A., Younossi Z.M., Gramilich T., Boparai N., Llu Y.C., McCullough A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413-1419.
4. La Vecchla C., Negr E., Decarli A., Franceschi S. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997, 73:204-207.
5. Adami H.O., Chow W.H., Nyren O., et al. Excess risk of primary liver cancer in patients with diabetes mellitus. JNatl Cancer Inst 1996, 88:1472-1477.
6. Lagiou P., Kuper H., Stuver S.O., Tzonou A., Trichopoulos D., Adami H.O. Role of diabetes in the etiology of hepatocellular carcinoma. JNatl Cancer Inst 2000, 96:2462-2467.
7. Picard C., Lambotte L., Starkel P. Steatosis is not sufficient to cause an impaired regenerative response after partial hepatectomy in rats. JHepatol 2002, 32:645-652.
8. Rao M.S., Papreddy K., Abecassis M., et al. Regeneration of liver with marked fatty change following partial hepatectomy in rats. Dig Dis Sci 2001, 46:1821-1826.
9. Behrns K.E., Tsiotos G.G., De Souza N.F., et al. Hepatic steatosis as a potential risk factor for major hepatic resection. JGastrointest Surg 1998, 2:292-298.
10. Susca M., Grassi A., Zauli D., et al. Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in non alcoholic steatohepatitis. Dig Dis Sci 2001, 33:768-777.
11. El-Serag H.B., Everhart J.E. Diabetes increases the risk of acute hepatic failure. Gastroenterology 2002, 122:1822-1828.
12. Krawczynski K., Aggarwal R. Hepatitis E. Schiff's Diseases of the Liver 2002, 877-890. Lippincott-Williams & Wilkins, Philadelphia. E.R. Schiff, M.F. Sorell, W.C. Maddrey (Eds.).
13. Mohanty S.K., Acharya S.K., Jha J.K., Dixit R.K., Panda S.K. IgM antibodies against hepatitis E (HEV) recombinant proteins and their importance in diagnosis of acute infection in endemic area. Indian J Gastroenterol 2003, 22(suppl 1):A5.
14. Case definition - acute viral hepatitis. Epidemiol Bull/PAHO 2002, 23:2.
15. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29(suppl 1):s43-s48.
16. The Third Report of the National Cholesterol Education Program Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report September 2002, National Institutes of Health, NIH Publication No. 02-5215.
17. Tandon B.N., Bernauau J., O'Grady J., et al. Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. JGastroenterol Hepatol 1999, 14:403-404.
18. Arroyo V., Gines P., Gerbes A.L., et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996, 23:164-176.
19. Kumar M., Satapathy S., Monga R., et al. Arandomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology 2007, 45:97-101.
20. O'Grady J.G., Alexander G.J.M., Hayllar K.M., Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989, 97:439-445.
21. Acharya S.K., Dasarathy S., Kumer T.L., et al. Fulminant hepatitis in a tropical population: clinical course, cause and early predictors of outcome. Hepatology 1996, 23:1448-1455.
22. Vento S., Garofano T., Renzine C., et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. NEngl J Med 1998, 338(5):286-290.
23. Kumar A., Aggarwal R., Naik S.R., Saraswat V., Ghoshal U.C., Naik S. Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Indian J Gastroenterol 2004, 23:59-62.
24. Hamid S.S., Atiq M., Shehzad F., et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002, 36:474-478.
25. Monga R., Garg S., Tyagi P., Kumar N. Superimposed acute hepatitis E infection in patients with chronic liver disease. Indian J Gastroenterol 2004, 23:50-52.
26. Ramachandran J., Eapen C.E., Kang G., et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. JGastroenterol Hepatol 2004, 19:134-138.
27. Pradeepa R., Mohan V. The changing scenario of the diabetes epidemic: implications for India. Indian J Med Res 2002, 116:121-132.
28. Anjana R.M., Pradeepa R., Deepa M., ICMR-INDIAB Collaborative Study Group, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study. Diabetologia 2011, 54:3022-3027.
29. Chan K.A., Truman A., Gurwitz J.H., et al. Acohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med 2003, 163:728-734.
30. Tolman K.G., Dapiaz A. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care 2007, 30:734-743.
31. Tandon B.N., Gandhi B.M., Joshi Y.K. Etiological spectrum of viral hepatitis and prevalence of markers of hepatitis A and B virus infection in north India. Bull World Health Organ 1984, 62:67-73.
32. Rana S.S., Rajan A., Kar P. The spectrum of sporadic acute viral hepatitis in North India: experience of a tertiary care centre. Indian J Gastroenterol 2000, 19:A31.
33. Tandon B.N., Acharya S.K., Tandon A. Epidemiology of hepatitis B virus infection in India. Gut 1996, 38(suppl 2):S56-S59.
34. DeAngelis R.A., Markiewski M.M., Taub R., Lambris J.D. Ahigh-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappaB inhibitor, I-kappaB alpha. Hepatology 2005, 42:1148-1157.
35. Torbenson M., Yang S.Q., Liu H.Z., Huang J., Gage W., Diehl A.M. STAT-3 over expression and p21 up-regulation accompany impaired regeneration of fatty livers. Am J Pathol 2002, 161:155-161.